Hellow guys, Welcome to my website, and you are watching Catalyst could be big winner in 2024 - CPRX is an undervalued small cap company with high upside. and this vIdeo is uploaded by Victor H Investing at 2023-11-27T00:00:27-08:00. We are pramote this video only for entertainment and educational perpose only. So, I hop you like our website.
| Name | Catalyst could be big winner in 2024 - CPRX is an undervalued small cap company with high upside |
| Video Uploader | Video From Victor H Investing |
| Upload Date | This Video Uploaded At 27-11-2023 08:00:27 |
| Video Discription | Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases. With the patient focus, the Company is engaged in developing a robust pipeline of cutting-edge, medicines for rare diseases. The Company's New Drug Application for FIRDAPSE (amifampridine) tablets 10 milligrams (mg) for the treatment of adults with Lambert-Eaton myasthenic syndrome (LEMS). The Company's FIRDAPSE is commercially available in the United States as a treatment for adults with LEMS. The Company also has FYCOMPA (perampanel) CIII, a prescription medicine approved in people with epilepsy aged four and older alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures and with other medicines to treat primary generalized tonic-clonic seizures for people with epilepsy aged 12 and older. |
| Category | Education |
| Tags | Education Download MP4 | Education Download MP3 | Education Download MP4 360p | Education Download MP4 480p | Education Download MP4 720p | Education Download MP4 1080p |
